Criptolat 50 mcg/ml Roztwór doustny
Criptolat 50 mcg/ml Roztwór doustny
Authorised
- Cabergoline
Product identification
Medicine name:
Criptolat 50 mcg/ml Roztwór doustny
Active substance:
- Cabergoline
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cabergoline50.00/microgram(s)/millilitre1.00microgram(s)/millilitre
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG02CB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Available in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2904
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 7/02/2023
Labelling
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 7/02/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 7/02/2023
How useful was this page?:
